BUSTED: Aegerion CEO caught doing some fast-talking on 'Fast Money'
This article was originally published in Scrip
Aegerion Pharmaceuticals CEO Marc Beer learned one thing very clear last week: FDA officials apparently watch CNBC, specifically, the network's financial stock trading program Fast Money.
You may also be interested in...
Aegerion and QLT will unite to create a new company dubbed Novelion in a deal that could help both companies solve some long-standing issues.
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.